Do you work with patients who are experience sleep disorder as a result of menopause?
They may be eligible to enrol in this innovative national study, which aims to assess the potential effectiveness of medicinal cannabis in managing menopause related sleep disorder over a 6-month duration.
The National Institute of Complimentary Medicine at Western Sydney University and Cannim are seeking 60 participants for the study. Learn more to refer your patients at gem.grindstone.com.au/t/r-l-thkykiil-bikkjttiiu-n/
More information at westernsydney.edu.au/nicm/research/participate-in-research/menocann
Human Research Ethics Committee Approval: This clinical trial has been approved by Western Sydney University Human Research Ethics Committee (Approval Number: H16317).
This study is supported by Cannim Group Pty Ltd.
NICM Health Research Institute Chief Investigator: Dr Guoyan Yang, Tel: (02) 9685 4732, Email: e.yang@westernsydney.edu.au
Disclaimer: This article was provided by Western Sydney University and Cannim. While every effort has been made to ensure the information is accurate, North Western Melbourne Primary Health Network does not warrant or represent the accuracy, currency and completeness of any information or material included within.
